Intervention not reported
Insurer perspective (expenditures on medicines) · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Insurer perspective (expenditures on health care) · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Healthcare utilisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall healthcare utilisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Emergency department and hospitalisation · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Outpatient care · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health outcomes · vulnerable population: senior 65 years of age or older
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: improvement in symptoms (respiratory distress/dyspnoea) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: improvement in symptoms (voice quality) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: improvement in quality of life · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Primary outcome: recurrence‐free interval · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in mortality · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in number and/or frequency of surgical interventions and/or time until first relapse requiring surgery · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in number and/or duration of hospital stay(s) · 23 patients aged two years or older with recurrent respiratory papillomatosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Reduction in volume of disease, assessed endoscopically · 23 patients aged two years or older with recurrent respiratory papillomatosis
1 finding from 1 review
Side effects · Adults, 16 years and older (dentate)
Oral cancer mortality (disease-specific) · Apparently healthy adults aged 35 years or older (general population), living in 13 clusters in rural areas of Trivandrum city, Kerala,…
Visual screening (oral visual inspection) by trained health workers showed no clear difference in oral cancer mortality (disease-specific) compared with no screening (low certainty).
2 findings from 1 review
Bad breath (halitosis) · Adults, 16 years and older (dentate)
The review found no eligible studies for this question.
1 finding from 1 review
Gingivitis · Adults, 16 years and older (dentate)
Interdental brushing plus toothbrushing may leads to lower gingivitis (bleeding and gingival indices; standardised across… compared with flossing plus toothbrushing (low certainty).
Costs · Apparently healthy adults aged 35 years or older (general population), living in 13 clusters in rural areas of Trivandrum city, Kerala,…
1 finding from 1 review